FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Noven Pharmaceuticals Daytrana Recall

Daytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Man…

Noven Pharmaceuticals Inc · Miami, FL

Risk level
Class II
Reported by FDA
Mar 29, 2023
Recall ID
D-0471-2023
Check your lot numberHow we source this data

Summary

Noven Pharmaceuticals recalled Daytrana starting Mar 10, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0471-2023 on Mar 29, 2023. Reason: Defective Delivery System: Out of specification for shear. Status: Ongoing.

Why it was recalled

Defective Delivery System: Out of specification for shear.

Product description

Daytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5553-3

Lot numbers, UPCs & expiration codes

Lot#: 91956, Exp. 6/2023; 92475, Exp. 7/2023

Where it was sold

US Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0471-2023
Classification
Class II
Status
Ongoing
Recall initiated
Mar 10, 2023
FDA report date
Mar 29, 2023
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Noven Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0471-2023, exactly as published.

Show all FDA fields
City
Miami
State
FL
Status
Ongoing
Country
United States
Event ID
91882
Address
11960 Sw 144th St
Code information
Lot#: 91956, Exp. 6/2023; 92475, Exp. 7/2023
Postal code
33186-6109
Report date
Mar 29, 2023
Product type
Drugs
Recall number
D-0471-2023
Classification
Class II
Recalling firm
Noven Pharmaceuticals Inc
Reason for recall
Defective Delivery System: Out of specification for shear.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Daytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5553-3
Distribution pattern
US Nationwide
Recall initiation date
Mar 10, 2023
Initial firm notification
Letter
Center classification date
Mar 20, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0471-2023, published Mar 29, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls